Graefen M - Search Results

1

Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.

van der Poel H, Klotz L, Andriole G, Azzouzi AR, Bjartell A, Cussenot O, Hamdy F, Graefen M, Palma P, Rivera AR, Stief CG. van der Poel H, et al. Among authors: graefen m. World J Urol. 2015 Jul;33(7):907-16. doi: 10.1007/s00345-015-1603-7. Epub 2015 Jun 3. World J Urol. 2015. PMID: 26037891

2

Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.

Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H. Haese A, et al. Among authors: graefen m. J Urol. 1997 Dec;158(6):2188-92. doi: 10.1016/s0022-5347(01)68192-8. J Urol. 1997. PMID: 9366341

3

The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer.

Noldus J, Graefen M, Huland E, Busch C, Hammerer P, Huland H. Noldus J, et al. Among authors: graefen m. J Urol. 1998 Jun;159(6):2004-7; discussion 2007-8. doi: 10.1016/S0022-5347(01)63227-0. J Urol. 1998. PMID: 9598507

4

Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H. Haese A, et al. Among authors: graefen m. J Urol. 1999 Apr;161(4):1206-11. J Urol. 1999. PMID: 10081870 Clinical Trial.

5

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H. Graefen M, et al. Eur Urol. 1999;36(1):21-30. doi: 10.1159/000019922. Eur Urol. 1999. PMID: 10364651

6

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

Haese A, Becker C, Noldus J, Graefen M, Huland E, Huland H, Lilja H. Haese A, et al. Among authors: graefen m. J Urol. 2000 May;163(5):1491-7. doi: 10.1016/s0022-5347(05)67649-5. J Urol. 2000. PMID: 10751864

7

Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.

Hautmann SH, Conrad S, Henke RP, Erbersdobler A, Simon J, Straub M, Graefen M, Hautmann RE, Huland H. Hautmann SH, et al. Among authors: graefen m. J Urol. 2000 Jun;163(6):1734-8. J Urol. 2000. PMID: 10799171 Free article.

8

Stage migration in clinically localized prostate cancer.

Noldus J, Graefen M, Haese A, Henke RP, Hammerer P, Huland H. Noldus J, et al. Among authors: graefen m. Eur Urol. 2000 Jul;38(1):74-8. doi: 10.1159/000020255. Eur Urol. 2000. PMID: 10859445

9

Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.

Conrad S, Graefen M, Pichlmeier U, Henke RP, Erbersdobler A, Hammerer PG, Huland H. Conrad S, et al. Among authors: graefen m. J Urol. 2002 Feb;167(2 Pt 1):521-5. doi: 10.1016/S0022-5347(01)69077-3. J Urol. 2002. PMID: 11792910

10

Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Huland E, Scardino PT, Kattan MW, Huland H. Graefen M, et al. J Urol. 2002 Mar;167(3):1306-9. J Urol. 2002. PMID: 11832719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

965 results

Search Page

Filters